{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:32:17Z","timestamp":1761129137740},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,1,18]],"date-time":"2014-01-18T00:00:00Z","timestamp":1390003200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s00345-013-1228-7","type":"journal-article","created":{"date-parts":[[2014,1,17]],"date-time":"2014-01-17T17:29:52Z","timestamp":1389979792000},"page":"1119-1125","source":"Crossref","is-referenced-by-count":31,"title":["Consistent and significant improvement of nighttime voiding frequency (nocturia) with silodosin in men with LUTS suggestive of BPH: pooled analysis of three randomized, placebo-controlled, double-blind phase III studies"],"prefix":"10.1007","volume":"32","author":[{"given":"Andreas","family":"Eisenhardt","sequence":"first","affiliation":[]},{"given":"Tim","family":"Schneider","sequence":"additional","affiliation":[]},{"given":"Francisco","family":"Cruz","sequence":"additional","affiliation":[]},{"given":"Matthias","family":"Oelke","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2014,1,18]]},"reference":[{"key":"1228_CR1","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1464-410X.2009.08969.x","volume":"105","author":"MM Dijk van","year":"2010","unstructured":"van Dijk MM, Wijkstra H, Debruyne FM et al (2010) The role of nocturia in the quality of life of men with lower urinary tract symptoms. BJU Int. 105:1141\u20131146","journal-title":"BJU Int."},{"key":"1228_CR2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/nau.10053","volume":"21","author":"P Kerrebroeck van","year":"2002","unstructured":"van Kerrebroeck P, Abrams P, Chaikin D et al (2002) The standardisation of terminology in nocturia: report from the standardisation sub-committee of the International Continence Society. Neurourol Urodyn 21:179\u2013183","journal-title":"Neurourol Urodyn"},{"key":"1228_CR3","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","volume":"50","author":"DE Irwin","year":"2006","unstructured":"Irwin DE, Milsom I, Hunskaar S et al (2006) Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 50:1306\u20131314","journal-title":"Eur Urol"},{"key":"1228_CR4","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.eururo.2009.03.080","volume":"57","author":"KA Tikkininen","year":"2010","unstructured":"Tikkininen KA, Johnson TM 2nd, Tammela TL et al (2010) Nocturia frequency, bother, and quality of life: how often is too often? A population-based study in Finland. Eur Urol 57:488\u2013496","journal-title":"Eur Urol"},{"key":"1228_CR5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S1569-9056(05)80002-8","volume":"3","author":"P Abrams","year":"2005","unstructured":"Abrams P (2005) Nocturia: the major problem in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction (LUTS\/BPO). Eur Urol Suppl 3:8\u201316","journal-title":"Eur Urol Suppl"},{"key":"1228_CR6","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1016\/j.juro.2011.07.008","volume":"186","author":"B Doorn van","year":"2011","unstructured":"van Doorn B, Blanker MH, Kok ET et al (2011) Once nocturia, always nocturia? Natural history of nocturia in older men based on frequency-volume charts: the Krimpen study. J Urol 186:1956\u20131961","journal-title":"J Urol"},{"key":"1228_CR7","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0022-5347(05)00245-4","volume":"175","author":"KA Tikkinen","year":"2006","unstructured":"Tikkinen KA, Tammela TL, Huhtala H, Auvinen A (2006) Is nocturia equally common among men and women? A population based study in Finland. J Urol 175:596\u2013600","journal-title":"J Urol"},{"key":"1228_CR8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1442-2042.2008.02246.x","volume":"16","author":"T Schneider","year":"2009","unstructured":"Schneider T, de la Rosette JJ, Michel MC (2009) Nocturia: a non-specific but important symptom of urological disease. Int J Urol 16:249\u2013256","journal-title":"Int J Urol"},{"key":"1228_CR9","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1016\/j.juro.2009.02.034","volume":"181","author":"LS Marks","year":"2009","unstructured":"Marks LS, Gittelman MC, Hill LA et al (2009) Rapid efficacy of the highly selective alpha1A-adrenoceptor antagonist silodosin in men with signs and symptoms of benign prostatic hyperplasia: pooled results of 2 phase 3 studies. J Urol 181:2634\u20132640","journal-title":"J Urol"},{"key":"1228_CR10","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.eururo.2010.10.046","volume":"59","author":"CR Chapple","year":"2011","unstructured":"Chapple CR, Montorsi F, Tammela TL et al (2011) Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe. Eur Urol 59:342\u2013352","journal-title":"Eur Urol"},{"key":"1228_CR11","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0022-5347(05)65406-7","volume":"167","author":"Y Homma","year":"2002","unstructured":"Homma Y, Yamaguchi T, Kondo Y et al (2002) Significance of nocturia in the international prostate symptom score for benign prostatic hyperplasia. J Urol 167:172\u2013176","journal-title":"J Urol"},{"key":"1228_CR12","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0302-2838(02)00041-6","volume":"41","author":"D Mitropoulos","year":"2002","unstructured":"Mitropoulos D, Anastasiou I, Giannopoulou C et al (2002) Symptomatic benign prostatic hyperplasia: impact on partners\u2019 quality of life. Eur Urol 41:240\u2013244","journal-title":"Eur Urol"},{"key":"1228_CR13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.eururo.2011.05.065","volume":"61","author":"V Kupelian","year":"2012","unstructured":"Kupelian V, Wei JT, O\u2019Leary MP et al (2012) Nocturia and quality of life: results from the Boston area community health survey. Eur Urol 61:78\u201384","journal-title":"Eur Urol"},{"key":"1228_CR14","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.eursup.2007.01.004","volume":"6","author":"T Schneider","year":"2007","unstructured":"Schneider T, Stanley N (2007) Impact of nocturia on sleep and energy. Eur Urol Suppl 6:585\u2013593","journal-title":"Eur Urol Suppl"},{"key":"1228_CR15","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.eursup.2010.03.006","volume":"9","author":"MC Michel","year":"2010","unstructured":"Michel MC (2010) The pharmacological profile of the alpha(1A)-adrenoceptor antagonist silodosin. Eur Urol Suppl 9:486\u2013490","journal-title":"Eur Urol Suppl"},{"key":"1228_CR16","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.eursup.2011.08.001","volume":"10","author":"A Russo","year":"2011","unstructured":"Russo A, Hedlund P, Montorsi F (2011) Silodosin from bench to bedside: selectivity, safety, and sustained efficacy. Eur Urol Suppl. 10:445\u2013450","journal-title":"Eur Urol Suppl."},{"key":"1228_CR17","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1111\/j.1464-410X.2010.09972.x","volume":"107","author":"AL Smith","year":"2011","unstructured":"Smith AL, Wein AJ (2011) Outcomes of pharmacological management of nocturia with non-antidiuretic agents: does statistically significant equal clinically significant? BJU Int 107:1550\u20131554","journal-title":"BJU Int"},{"key":"1228_CR18","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.eururo.2013.03.004","volume":"64","author":"M Oelke","year":"2013","unstructured":"Oelke M, Bachmann A, Descazeaud A et al (2013) EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 64:118\u2013140","journal-title":"Eur Urol"},{"key":"1228_CR19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.eururo.2004.11.012","volume":"48","author":"MC Michel","year":"2005","unstructured":"Michel MC, de la Rosette JJ, Piro M, Schneider T (2005) Comparison of symptom severity and treatment response in patients with incontinent and continent overactive bladder. Eur Urol 48:110\u2013115","journal-title":"Eur Urol"},{"key":"1228_CR20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/nau.21224","volume":"31","author":"Y Kojima","year":"2012","unstructured":"Kojima Y, Sasaki S, Imura M et al (2012) Tamsulosin reduces nighttime urine production in benign prostatic hyperplasia patients with nocturnal polyuria: a prospective open-label long-term study using frequency-volume chart. Neurourol Urodyn 31:80\u201385","journal-title":"Neurourol Urodyn"},{"key":"1228_CR21","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.juro.2008.05.050","volume":"180","author":"ES Rovner","year":"2008","unstructured":"Rovner ES, Kreder K, Sussman DO et al (2008) Effect of tolterodine extended release with or without tamsulosin on measures of urgency and patient reported outcomes in men with lower urinary tract symptoms. J Urol 180:1034\u20131041","journal-title":"J Urol"},{"key":"1228_CR22","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/j.juro.2007.07.013","volume":"178","author":"TM Johnson 2nd","year":"2007","unstructured":"Johnson TM 2nd, Burrows PK, Kusek JW et al (2007) The effect of doxazosin, finasteride and combination therapy on nocturia in men with benign prostatic hyperplasia. J Urol 178:2045\u20132050","journal-title":"J Urol"},{"key":"1228_CR23","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.eururo.2012.01.013","volume":"61","author":"M Oelke","year":"2012","unstructured":"Oelke M, Giuliano F, Mirone V et al (2012) Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomized, parallel, placebo-controlled clinical trial. Eur Urol 61:917\u2013925","journal-title":"Eur Urol"},{"key":"1228_CR24","doi-asserted-by":"crossref","unstructured":"Oelke M, Weiss JP, Mamoulakis C et al (2014) Effects of tadalafil on night-time voiding (nocturia) in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a post hoc analysis of pooled data from four randomized, placebo-controlled clinical studies. World J Urol (submitted)","DOI":"10.1007\/s00345-014-1255-z"},{"key":"1228_CR25","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/ijcp.12194","volume":"67","author":"VW Nitti","year":"2013","unstructured":"Nitti VW, Khullar V, van Kerrebroeck P et al (2013) Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies. Int J Clin Pract 67:619\u2013632","journal-title":"Int J Clin Pract"},{"key":"1228_CR26","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.eururo.2008.02.017","volume":"54","author":"M Oelke","year":"2008","unstructured":"Oelke M, Baard J, Wijkstra H et al (2008) Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia. Eur Urol 54:419\u2013426","journal-title":"Eur Urol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-013-1228-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-013-1228-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-013-1228-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T19:14:12Z","timestamp":1565118852000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-013-1228-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,18]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["1228"],"URL":"https:\/\/doi.org\/10.1007\/s00345-013-1228-7","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,18]]}}}